Healthcare Update

April 2026

What Changed This Period

Medicare and Medicaid Administration: New requirements continued to affect reimbursement, program integrity, prior authorization, and state payment structures.

Drug and Device Oversight: FDA and DEA activity touched pharmaceutical labeling, controlled-substance handling, medical devices, diagnostics, and healthcare technology.

Operational Compliance: Healthcare organizations faced updates involving emergency medical services, provider obligations, documentation, and risk management.

What It Means for Healthcare Organizations

The first part of 2026 showed how healthcare compliance is becoming more interconnected. Payment rules, drug oversight, medical technology, and operational requirements increasingly affect the same teams inside healthcare organizations.

Recent CourseAvenue offerings covered updates to DMEPOS ordering and prior authorization, new expectations around Medicaid healthcare-related tax waivers, and controlled-substance standards for emergency medical services.

Medical technology also remained active. Our course on software-aided diagnostic devices for skin lesions reflects the growing need for healthcare professionals to understand how technology, safety, and regulatory review fit together.